Cirius Therapeutics, Inc., a developer of innovative therapies for people suffering from diseases caused by mitochondrial ...

Only after 300 years did diabetes enter the "realm of management." In 1957, French medical scientist Jean Stern successfully ...

MannKind posted Phase 3 trial results last October, comparing Afrezza in patients aged 4 to 17, with multiple daily insulin ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the autoimmune disease.

More than 5.8 million people are thought to be living with diabetes in the UK and 90% of cases are type 2. This form of the ...

It’s likely you’ve gotten into a rhythm when it comes to managing your type 2 diabetes (T2D). Yet, between your medication and lifestyle habits, treatment isn’t always a “set it and forget it” type of ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes (TIND) ...

Johns Hopkins engineers are developing treatments for Type 1 diabetes that don't rely on daily insulin injections or wearing an insulin pump to manage blood sugar levels. Instead, their new cell-based ...

Metformin is particularly effective for people with diabetes or prediabetes who have obesity and have difficulty managing their blood sugar through lifestyle changes alone. Metformin is a widely used ...

The findings of this study are important because most research on type 2 diabetes focuses on people who are overweight or ...